Gregory John Moran, MD, FACEP
Emergency Medicine Dept. & Infectious Diseases Service, Olive View-UCLA Medical Center

Dept of Emergency Medicine
Olive View-UCLA Medical Center
14445 Olive View Drive
Sylmar, CA 91342
Phone: (818) 364-3110
Fax: (818) 364-3268
gmoran@ucla.edu

Research Interests focus primarily on infectious diseases in the emergency department. Dr. Moran is co-investigator for the EMERGEncy ID Net, a nationwide network of emergency departments funded through a cooperative agreement grant from the Centers for Disease Control and Prevention to study emerging infectious diseases. He is also Co-principal investigator on an NIH sponsored multi-center study of off-patent oral antibiotics for the treatment of MRSA skin and soft tissue infections. Areas of study include MRSA skin and soft tissue infections, MRSA as a cause of community-acquired pneumonia, impact of antimicrobial resistance on outcomes in urinary tract infections, infection control for MRSA and tuberculosis, rabies prophylaxis for animal bites, and C. difficile as a cause of community-acquired diarrhea. Dr. Moran is also involved in several clinical trials in the emergency department, including antimicrobials for skin and soft tissue infections, community-acquired pneumonia, and newer diagnostic tests for identifying the etiology of skin and soft tissue infections and early identification of sepsis.

Selected Publications:

  1. Talan DA, Citron DM, Abrahamian FM, Moran GJ, Goldstein EJC, the Emergency Medicine Animal Bite Infection Study Group. Bacteriologic analysis of infected dog and cat bites.  New Engl J Med 1999; 340 (2): 85-92.     
  2. Talan DA, Stamm WE, Hooton TM,Moran GJ, Burke T, Iravani A, Reuning-Scherer J, Church DA. Short-Course Ciprofloxacin for Acute Uncomplicated Pyelonephritis in Women:A Randomized, Double-Blind Study.  JAMA 2000; 283 (12):1583-1590.
  3. Moran GJ, Talan DA, Mower W, Newdow M, Ong S, Nakase JY, Pinner RW, Childs JE, for the Emergency ID Net Study Group. Appropriateness of Rabies Postexposure Prophylaxis Treatment for Animal Exposures.  JAMA 2000; 284: 1001-1007.
  4. Talan DA, Moran GJ.  Why did the chicken cross the road? ..To get the antibiotics. (editorial) Ann Emerg Med 2000; 36: 353-355.
  5. Moran GJ.  Pharmacologic management of HIV/STD exposure.  Emerg Med Clin North Am 2000; 18: 829-842.
  6. Talan DA, Moran GJ, Newdow M, Ong S, Mower WR, Nakase JY, Pinner RW, Slutsker L, for the EMERGEncy ID Net Study Group.  Etiology of Bloody Diarrhea among Patients Presenting to U.S. Emergency Departments: Prevalence of E. coli O157:H7 and Other Enteropathogens.  Clin Infect Dis 2001:32:573-580.
  7. Moran GJ.  Dogs, cats, raccoons and bats: Where is the real risk for rabies? (editorial) Ann Emerg Med 2002; 39: 541-543.
  8. Ong S, Talan DA, Moran GJ, Mower W, Newdow M, Tsang VCW, Pinner RW, and the EMERGEncy ID Net Study Group.  Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments.  Emerg Infect Dis 2002; 8: 608-613.
  9. Moran GJ.  Threats in bioterrorism: CDC category B and C agents. Emerg Med Clin North Am 2002 May; 20(2):311-30.
  10. Frank E, Liu J, Kinasewitz G, Moran GJ, Oross MP, Olson WH, Reichl V, Frietag S, Bahal N, Weisinger BA, Tennenberg A, Kahn JB.  A multicenter, open label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community acquired pneumonia.  Clin Ther 2002 Aug;24(8): 1292-308.
  11. Moran GJ, Mount J.  CDC Update Commentary-Staphylococcus aureus resistant to vancomycin-United States, 2002.  Ann Emerg Med 2003; 41:148-151.
  12. Moran GJ, Talan DA.  CDC Update Commentary-Syndromic surveillance for bioterrorism following the attacks on the world trade center-New York City, 2001.  Ann Emerg Med 2003;41:417-418.
  13. Moran GJ, Worth WE, Karras DJ, Pesik NT, Sztajnkrycer MD.  Smallpox vaccination for emergency physicians: Joint statement of the AAEM and SAEM.  Jour Emerg Med 2003;24:351-352.
  14. Talan DA, Abrahamian FM, Moran GJ, Citron DM, Tan JO, Goldstein EJC, the Emergency Medicine Human Bite Infection Study Group.  Clinical presentation and bacteriologic analysis of infected human bites in patients presenting to emergency departments.  Clin Infect Dis 2003; 37:1481-9.
  15. Karras DJ, Ong S, Moran GJ, Nakase J, Kuehnert MJ, Jarvis, WR, Talan DA, The EMERGEncy ID Net Study Group.  Antibiotic use for emergency department patients with acute diarrhea: Prescribing practices, patient expectations, and patient satisfaction.  Ann Emerg Med 2003;42 (6):835-42.
  16. Talan DA, Abrahamian FM, Moran GJ, Mower WR, Alagappan K, Tiffany B, Pollack CV, Steele M, Dunbar L, Weyant RS, Ostroff S. Tetanus Immunity and Physician Compliance with Tetanus Prophylaxis Practices Among Emergency Department Patients Presenting With Wounds.  Ann Emerg Med 2004;43(3):305-14.
  17. Moran GJ, Talan DA.  Methicillin-resistant Staphylococcus aureus: Is it in your community and should it change practice? (editorial) Ann Emerg Med 2005; 45:321-322.
  18. Moran GJ, Amii RN, Abrahamian FM, Talan DA. Methicillin-Resistant Staphylococcus aureus in Community-Acquired Skin Infections.  Emerg Infect Dis 2005; 11(6):928-930.
  19. Moran GJ, Abrahamian FM.  Blood cultures for pneumonia: Can we hit the target without a shotgun? (editorial) Ann Emerg Med 2005;46:407-408.
  20. Abrahamian FM, Moran GJ, Talan DA.  Community-acquired bacterial meningitis. (letter to editor) New Engl J Med 2006; 354:1429.
  21. Moran GJ. Approaches to treatment of community-acquired pneumonia in the emergency department and the appropriate role of fluoroquinolones.  J Emerg Med 2006;30(4):377-87.
  22. Nguyen HB, Rivers EP, Abrahamian FM, Moran GJ, Abraham E, Trzeciak S, Huang DT, Osborn T, Stevens D, Talan DA.  Severe sepsis and septic shock: review of the literature and emergency department management guidelines.  Ann Emerg Med 2006;48:28-54.
  23. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, Talan DA, for The EMERGEncy ID Net Study Group. Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department.  New Engl J Med 2006;355:666-74.
  24. Rothman RE, Irvin CB, Moran GJ, Sauer L, Bradshaw US, Fry RB, Josephine EB, Ledyard HK, Hirshon JM.  Respiratory Hygiene in the Emergency Department.  Ann Emerg Med 2006;48:570-82.
  25. Ong S, Nakase J, Moran GJ, Karras DJ, Kuehnert MJ, Talan DA, The EMERGEncy ID Net Study Group. Antibiotic Use for Emergency Department Patients With Upper Respiratory Infections:  Prescribing Practices, Patient Expectations, and Patient Satisfaction. Ann Emerg Med 2007;50(3):213-20.
  26. Talan DA, Moran GJ, Abrahamian FM. Severe sepsis and septic shock.  Infect Dis Clin North Am 2008;22(1):1-31.
  27. Fitch MT, Abrahamian FM, Moran GJ, Talan DA.  Emergency department management of meningitis and encephalitis.  Infect Dis Clin North Am 2008;22(1):33-52.
  28. Moran GJ, Talan DA, Abrahamian FM. Diagnosis and management of pneumonia in the emergency department.  Infect Dis Clin North Am 2008;22(1):53-72.
  29. Abrahamian FM, Moran GJ, Talan DA. Urinary tract infections in the emergency department.  Infect Dis Clin North Am 2008;22(1):73-87.
  30. Abrahamian FM, Talan DA, Moran GJ. Management of skin and soft tissue infections in the emergency department.  Infect Dis Clin North Am 2008;22(1):89-116
  31. Moran GJ, Talan DA, Abrahamian FM. Antimicrobial prophylaxis for wounds and procedures in the emergency department.  Infect Dis Clin North Am 2008;22(1): 117-143.
  32. Moran GJ, Talan DA, Abrahamian FM. Biological terrorism.  Infect Dis Clin North Am 2008;22(1): 145-187.

 


2008